NCT05355701 2026-05-14A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.PfizerPhase 1 Recruiting267 enrolled
NCT05786924 2026-04-21Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive MalignanciesServierPhase 1/2 Recruiting554 enrolled